logo

For the Inventor, By the Inventor

Columbia, MD, United States of America

Osiris Therapeutics, Inc.


USPTO Granted Patents = 72

% Expired Patents = 8.3



Trademarks = 11

Forward Citations = 6,050

Loading Chart...
Loading Chart...

75 inventors (with patents filed for the assignee):

goldMedal Alla Danilkovitch (29 out of 38 patents)

silverMedal Jin-Qiang Kuang (25 out of 26 patents)

bronzeMedal Dana Sue Yoo (19 out of 19 patents)

4.  Samson Tom (19 out of 25 patents)

5.  Timothy Jansen (15 out of 15 patents)

6.  Jennifer Michelle Marconi (14 out of 14 patents)

7.  Mark F Pittenger (9 out of 23 patents)

8.  Joseph D Mosca (9 out of 11 patents)

9.  Kevin R McIntosh (8 out of 9 patents)

10.  Scott Philip Bruder (8 out of 10 patents)

11.  Arnold I Caplan (7 out of 22 patents)

12.  Elena N Klyushnenkova (6 out of 7 patents)

13.  Stephen E Haynesworth (6 out of 13 patents)

14.  Stephen L Gordon (5 out of 19 patents)

15.  Alastair Morgan Mackay (5 out of 11 patents)


Core Competencies:
Mesenchymal Stem Cells
Immunocompatible Membranes
Tissue Regeneration
Bone Repair
Cartilage Products
Vitalized Placental Dispersions
Human Tissue Compositions
Adipogenic Differentiation
Hematopoietic Stem Cells
Wound Treatment
Immune Response Suppression
Cardiac Muscle Regeneration

72 patents:

1. 12558377 - Immunocompatible chorionic membrane products (2026-02-24),
2. 12343446 - Bone repair product and methods of use thereof (2025-07-01),
3. 12318408 - Methods of manufacture of therapeutic products comprising vitalized placental dispersions (2025-06-03),
4. 12310993 - Human tissue derived compositions and uses thereof (2025-05-27),
5. 12268797 - Non-cultured, partially digested, cryopreserved cartilage product (2025-04-08),
6. 12109241 - Methods of manufacture of immunocompatible chorionic membrane products (2024-10-08),
7. 11986498 - Therapeutic products comprising vitalized placental dispersions (2024-05-21),
8. 11638725 - Methods of manufacture of immunocompatible chorionic membrane products (2023-05-02),
9. 11590173 - Methods of manufacture of therapeutic products comprising vitalized placental dispersions (2023-02-28),
10. 11590172 - Immunocompatible chorionic membrane products (2023-02-28),
11. 11510947 - Methods of manufacture of immunocompatible amniotic membrane products (2022-11-29),
12. 11464809 - Umbilical tissue compositions and methods of use (2022-10-11),
13. 11413373 - Disrupted cartilage products (2022-08-16),
14. 11406735 - Methods of manufacturing cartilage products (2022-08-09),
15. 11318168 - Human tissue derived compositions and uses thereof (2022-05-03),
Osiris Therapeutics, Inc. is a leading biotechnology company focused on developing and commercializing regenerative medicine products to treat various medical conditions. They have developed innovative stem cell-based therapies for tissue repair, including wound healing, orthopedics, and sports medicine. Osiris Therapeutics is committed to improving patient outcomes and quality of life through their advanced therapeutic solutions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

72 Patents

#6 in Columbia, MD

#44 in Maryland

#5,099 in US

#10,377 in the World

Columbia, MD (US)
Columbia, MD, United States of America

Osiris Therapeutics, Inc.

Forward Citations = 6,050

75 inventors:

goldMedal Alla Danilkovitch (29 out of 38 patents)

silverMedal Jin-Qiang Kuang (25 out of 26 patents)

bronzeMedal Dana Sue Yoo (19 out of 19 patents)

4.  Samson Tom (19 out of 25 patents)

5.  Timothy Jansen (15 out of 15 patents)

Please report any incorrect information to [email protected]
Loading…